Company Link extends MIDAS sales data by providing segmented, historical, and forecasted sales at country- and disease-levels across 600 diseases, 350 therapy classes, and 75 countries. It integrates analyst consensus forecasts, reconciles under/over-reporting, and adds financial metrics like profit margins. Covering 200+ pharma firms, it offers 10 years of historical data and 7 years of forecasts. The tool enables competitive benchmarking, product analysis, and market predictions, helping companies assess catalysts and competitor performance.

Join for free to read